Interactions between novel terpenes and main components of rat and human skin: Mechanistic view for transdermal delivery of propranolol hydrochloride

Current Drug Delivery

Volumn 8, Issue 2, 2011, Pages 213-224

  Ahad, Abdul ^a   Aqil, Mohammed ^a   Kohli, Kanchan ^a   Sultana, Yasmin ^a   Mujeeb, Mohd ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

DSC; FT IR; Permeation enhancer; Propranolol hydrochloride; Terpenes; Transdermal

Indexed keywords

1,4 CINEOLE; BETA CITRONELLENE; CINEOLE; KERATIN; LIPID; PROPRANOLOL; ROSE OXIDE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BILAYER MEMBRANE; CADAVER; CONTROLLED STUDY; DENATURATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; EDEMA; ENERGY ABSORPTION; ENHANCER REGION; ERYTHEMA; FOURIER TRANSFORM MASS SPECTROMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; SKIN IRRITATION; SKIN PERMEABILITY; THERMOGRAPHY;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; EPIDERMIS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPID BILAYERS; MONOTERPENES; OILS, VOLATILE; PERMEABILITY; PHARMACEUTICAL VEHICLES; PHYSICOCHEMICAL PHENOMENA; PROPRANOLOL; RATS; SKIN; SKIN ABSORPTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TERPENES;

EID: 79551627450     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720111794479907     Document Type: Article

References (40)

1. Yach, D. Progress in Addressing Risk to Health: Implications to Mega Countries; World Health Organization (WHO) Mega Country meeting, Geneva, 2002.
2. Based on Indian Council of Medical Research (ICMR). Assessment of burden of non-communicable diseases in India. Final report of Project WR/SE IND RPC 001 RB 02. SE/02/419575. Indian Council of Medical Research; New Delhi, 2004.
3. Gupta, R. Trends in hypertension epidemiology in India. J. Hum. Hypertens., 2004, 18, 73-78.
4. Aqil, M.; Ali, A.; Sultana, Y.; Parvez, N. Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization. Eth. Pharm. J., 2004, 22, 55-50.
5. Aqil, M.; Sultana, Y.; Ali, A. Transdermal delivery of betablockers. Expert. Opin. Drug. Deliv., 2006, 3(3), 405-418.
6. Jantharaprapap, R.; Stagni, G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int. J. Pharm., 2007, 343(1-2), 26-33.
7. Rao, P.R.; Reddy, M.N.; Ramakrishna S, Diwan, P.V. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur. J. Pharm. Biopharm., 2003, 56, 81-85.
8. Dey, B.K.; Nath, L.K.; Mohanti, B.; Bhowmik, B.B. Development and evaluation of propranolol hydrochloride transdermal patches by using hydrophilic and hydrophobic polymer. Ind. J. Pharm. Educ. Res., 2007, 41(4), 388-393.
9. Amnuaikita, C.; Ikeuchia, I.; Ogawaraa, K.; Higakia, K.; Kimura, T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int. J. Pharm., 2005, 289, 167-178.
10. Gannu, R.; Vishnu, Y.V.; Kishan, V.; Rao, Y.M. Development of nitrendipine transdermal patches: In vitro and ex vivo characterization. Curr. Drug. Deliv., 2007, 4, 69-76.
11. Aqil, M.; Bhavna.; Chowdhary, I.; Sultana, Y.; Talegaonkar, S.; Ahmad, F. J.; Ali, M. M. Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer. Curr. Drug. Deliv., 2008, 5, 148-152.
12. Aqil, M.; Zafar, S.; Ali, A.; Ahmad, S. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization. Curr. Drug. Deliv., 2005, 2, 125-131.
13. Narishetty, S.T.K.; Panchagnula, R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J. Control Release, 2004, 95, 367-379.
14. Panchagnula, R.; Salve, P.S.; Thomas, N.S.; Jain, A.K.; Ramarao, P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm., 2001, 219, 95-105.
15. Shakeel, F.; Baboota, S.; Ahuja, A.; Ali, J.; Shafiq, S. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J. Nanobiotech., 2008, 6(8), 1-8.
16. Yamane, M.A.; Williams, A.C.; Barry, B.W. Terpenes penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and Mechanism of action. J. Pharm. Pharmacol., 1995, 47, 978-989.
17. Vaddi, H.K.; Ho, P.C.; Chan, S.Y. Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J. Pharm. Sci., 2002, 91, 1639-1651.
18. Rizwan, M.D.; Aqil, M.; Ahad, A.; Sultana, Y.; Ali, M. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug. Dev. Ind. Pharm., 2008, 34, 618-626.
19. Mura, S.; Manconi, M.; Sinico, C.; Valenti, D.; Fadda, A.M. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int. J. Pharm., 2009, 380, 72-79.
20. Moghimi, H.R.; Makhmalzadeh, B.S.; Manafi, A. Enhancement effect of terpenes on silver sulphadiazine permeation through thirddegree burn eschar. Burns, 2009, 35(8),1165-1170.
21. El-Saharty, Y. S. Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal., 2003, 33, 699-709.
22. Krishnaiah, Y.S.R.; Satyanarayana, V.; Bhaskar, P. Influence of Limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int. J. Pharm., 2002, 247, 91-102.
23. Al-Saidan, S.M.; Barry, B.W.; Williams, A.C. Differential scanning calorimetry of human and animal stratum corneum membranes. Int. J. Pharm., 1998, 168, 17-22.
24. Fang, C.; Liu, Y.; Ye, X.; Rong, Z.X.; Feng, X.M.; Jiang, C.B.; Chen, H.Z. Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur. J. Pharm. Biopharm., 2008, 68(3), 735-740.
25. Krishnaiah, Y.S.; Al-Saidan, S.M.; Chandrasekhar, D.V.; Satyanarayana, V. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J. Control. Rel., 2005, 106, 111-122.
26. Yun-Seok, R.; Si-Young, C.; Chun-Woong, P.; Sang-Cheol, C.; Eun-Seok, P. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int. J. Pharm., 2008, 364, 14-20.
27. Fang, J.Y.; Hung, C.F.; Chiu, HC.; Wang, J.J.; Chan, T.F. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin. J. Pharm. Pharmacol., 2003, 55, 593-601.
28. Ahad, A.; Aqil, M.; Kohli, K.; Chaudhary, H.; Sultana, Y.; Mujeeb, M.; Talegaonkar, S. Chemical penetration enhancers: a patent review. Expert. Opin. Ther. Pat., 2009, 19 (7), 969-988.
29. Jain, A.K.; Thomas, N.S.; Panchagula, R. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J. Control. Release, 2001, 79, 93-101.
30. Williams, A.C.; Barry, B.W. Penetration enhancers. Adv. Drug. Deliv. Rev., 2004, 56, 603-618.
31. Aqil, M.; Ahad, A.; Sultana, Y.; Ali, A. Status of terpenes as skin penetration enhancers. Drug. Dis. Today, 2007, 12, 1601-1607.
32. Hori, M.; Satoh, S.; Maibach, H.I.; Guy, R. H. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci., 1991, 80(1), 32-35.
33. Ogiso, T.; Iwaki, M.; Paku, T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci., 1995, 84, 482-488.
34. El-Kattan, A. F.; Asbill, C.S.; Kim, N.; Michniak, B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm., 2001, 215, 229-240.
35. Fujii, M.; Takeda, Y.; Yoshida, M.; Matsumoto, M.; Watanabe, Y. Enhancement Effect of p-menthane-3,8-diol on in vitro permeation of antipyrine and indomethacine through yucatan micropig skin. Drug. Dev. Ind. Pharm., 2004, 30, 673-677.
36. Cornwell, P.A.; Barry, B.W. In: Prediction of Percutaneous Penetration; Scott, R.C., Guy, R.H., Hadgraft, J. and Boddr, H.E., Eds.; IBC Technical Services, London, 1991; Vol. 2, pp. 394-400.
37. Goodman, M.; Barry, B.W. In: Percutaneous absorption; Bronaugh, R.L.; Maibach, H.I.; Eds.; Marcel Dekker: New York and Basel, 1989; pp. 567-593.
38. Jiang, S.J.; Hwang, S.M.; Choi, E.H.; Elias, P.M.; Ahn, S.K.; Lee, S.H. Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum. J. Invest. Dermatol., 2000, 114, 64-70.
39. Kandimalla, K.; Kanikannan, N.; Andega, S.; Singh, M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in vitro and on the transepidermal water loss in rats in vivo. J. Pharm. Pharmacol., 1999, 51, 783-790.
40. Tanojo, H.; Boelsma, E.; Junginger, H.E.; Ponec, M.; Bodde, H.E. In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study. J. Control. Release, 1999, 58, 97-104.